Last Updated:
Name Designation Appointment Date Status
Sujit Kumar Singh

Appointed as Director since January 2015

 Director 20-Jan-2015 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Senberk Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.
Vijaya Choudhary

Appointed as Director since January 2019

 Director 07-Jan-2019 Current
Arunjyoti Ghosal

Appointed as Director since January 2015

 Director 20-Jan-2015 Current
Biswa Ranjan Dash

Appointed as Managing Director since January 2015

 Managing Director 20-Jan-2015 Current

People Timeline

Explore the timeline of key personnel in Senberk Pharmaceuticals Private Limited's leadership journey.

Contact Details
  • Address Professor Para Sagadia Sahi, Ranihat, Cuttack Orissa, 753001, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 753001
  • Country India
  • Website -
Frequently Asked Questions
You can contact Senberk Pharmaceuticals Private Limited through their registered address at Professor Para Sagadia Sahi, Ranihat, Cuttack Orissa, 753001, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Senberk Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SUJIT KUMAR SINGH
  • VIJAYA CHOUDHARY
  • ARUNJYOTI GHOSAL
  • BISWA RANJAN DASH
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available